Sonolysis in Prevention of Brain Infarction During Cardiac Surgery (SONORESCUE): Randomized, Controlled Trial

David Školoudík, Eva Hurtíková, Radim Brát, Roman Herzig, SONORESCUE Trial Group, David Školoudík, Eva Hurtíková, Radim Brát, Roman Herzig, SONORESCUE Trial Group

Abstract

Here, we examined whether intraoperative sonolysis can alter the risk of new ischemic lesions in the insonated brain artery territory during coronary artery bypass grafting (CABG) or valve surgery.Silent brain ischemic lesions could be detected in as many as two-thirds of patients after CABG or valve surgery.Patients indicated for CABG or valve surgery were allocated randomly to sonolysis (60 patients, 37 males; mean age, 65.3 years) of the right middle cerebral artery (MCA) during cardiac surgery and control group (60 patients, 37 males; mean age, 65.3 years). Neurologic examination, cognitive function tests, and brain magnetic resonance imaging (MRI) were conducted before intervention as well as 24 to 72 hours and 30 days after surgery.New ischemic lesions on control diffusion-weighted MRI in the insonated MCA territory ≥0.5 mL were significantly less frequent in the sonolysis group than in the control group (13.3% vs 26.7%, P = 0.109). The sonolysis group exhibited significantly reduced median volume of new brain ischemic lesions (P = 0.026). Stenosis of the internal carotid artery ≥50% and smoking were independent predictors of new brain ischemic lesions ≥0.5 mL (odds ratio = 5.685 [1.272-25.409], P = 0.023 and 4.698 [1.092-20.208], P = 0.038, respectively). Stroke or transient ischemic attack occurred only in 2 control patients (P = 0.496). No significant differences were found in scores for postintervention cognitive tests (P > 0.05).This study provides class-II evidence that sonolysis during CABG or valve surgery reduces the risk of larger, new ischemic lesions in the brain.www.clinicaltrials.gov (NCT01591018).

Conflict of interest statement

The authors report no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Flow chart diagram of the study. mRS = modified Rankin score.

References

    1. Lisle TC, Barrett KM, Gazoni LM, et al. Timing of stroke after cardiopulmonary bypass determines mortality. Ann Thorac Surg 2008; 85:1556–1562.
    1. Almassi GH, Sommers T, Moritz TE, et al. Stroke in cardiac surgical patients: determinants and outcome. Ann Thorac Surg 1999; 68:391–397.
    1. Salazar JD, Wityk RJ, Grega MA, et al. Stroke after cardiac surgery: short- and long-term outcomes. Ann Thorac Surg 2001; 72:1195–1201.
    1. Müllges W, Babin-Ebell J, Reents W, et al. Cognitive performance after coronary artery bypass grafting: a follow-up study. Neurology 2002; 59:741–743.
    1. Zamvar V, Williams D, Hall J, et al. Assessment of neurocognitive impairment after off-pump and on-pump techniques for coronary artery bypass graft surgery: prospective randomised controlled trial. BMJ 2002; 325:1268.
    1. Carrascal Y, Casquero E, Gualis J, et al. Cognitive decline after cardiac surgery: proposal for easy measurement with a new test. Interact Cardiovasc Thorac Surg 2005; 4:216–221.
    1. Cook DJ, Huston J, 3rd, Trenerry MR, et al. Postcardiac surgical cognitive impairment in the aged using diffusion-weighted magnetic resonance imaging. Ann Thorac Surg 2007; 83:1389–1395.
    1. Sun X, Lindsay J, Monsein LH, et al. Silent brain injury after cardiac surgery: a review: cognitive dysfunction and magnetic resonance imaging diffusion-weighted imaging findings. J Am Coll Cardiol 2012; 60:791–797.
    1. Saqqur M, Tsivgoulis G, Nicoli F, et al. The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging 2014; 24:209–220.
    1. Tachibana S, Koga E. Ultrasonic vibration for boosting fibrinolytic effect of urokinase. Blood Vessel 1981; 12:450–453.
    1. Francis CW, Behrens S. Hennerici M, Meairs S. Ultrasonic thrombolysis. Cerebrovascular ultrasound. Cambridge: Cambridge University Press; 2001. 404–415.
    1. Francis CW, Onundarson PT, Carstensen EL, et al. Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest 1992; 90:2063–2068.
    1. Daffertshofer M, Fatar M. Therapeutic ultrasound in ischemic stroke treatment: experimental evidence. Eur J Ultrasound 2002; 16:121–130.
    1. Ishibashi T, Akiyama M, Onoue H, et al. Can transcranial ultrasonication increase recanalization flow with tissue plasminogen activator? Stroke 2002; 33:917–925.
    1. Alexandrov AV, Molina CA, Grotta JC, et al. CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351:2170–2178.
    1. Eggers J, König IR, Koch B, et al. Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke 2008; 39:1470–1475.
    1. Eggers J, Seidel G, Koch B, et al. Sonothrombolysis in acute ischemic stroke for patients ineligible for rt-PA. Neurology 2005; 64:1052–1054.
    1. Skoloudik D, Bar M, Skoda O, et al. Safety and efficacy of the sonographic acceleration of the middle cerebral artery recanalization: results of the pilot thrombotripsy study. Ultrasound Med Biol 2008; 34:1775–1782.
    1. Francis CW, Blinc A, Lee S, et al. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995; 21:419–424.
    1. Blinc A, Francis CW, Trudnowski JL, et al. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood 1993; 81:2636–2643.
    1. Brat R, Horacek J, Sieja J. Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: a leg-related morbidity and histological comparison. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013; 157:70–74.
    1. Brat R, Tosovsky J, Januska J. Myocardial function in early hours after coronary artery bypass grafting in patients with left ventricular dysfunction. Comparison of blood and crystalloid cardioplegia. J Cardiovasc Surg 2004; 45:265–269.
    1. Kuliha M, Roubec M, Goldírová A, et al. Laboratory-based markers as predictors of brain infarction during carotid stenting: a prospective study. J Atheroscler Thromb 2016; doi: 10.5551/jat.31799.[Ahead of Print].
    1. Bendszus M, Stoll G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol 2006; 5:364–372.
    1. Knipp SC, Matatko N, Wilhelm H, et al. Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging. Eur J Cardiothorac Surg 2004; 25:791–800.
    1. Knipp SC, Matatko N, Schlamann M, et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg 2005; 28:88–96.
    1. Ricci S, Dinia L, Del Sette M, et al. Sonothrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2012; 10:CD008348.
    1. Tsivgoulis G, Eggers J, Ribo M, et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke 2010; 41:280–287.
    1. Školoudík D, Kuliha M, Hrbáč T, et al. Sonolysis in Prevention of Brain Infarction during Carotid Endarterectomy and Stenting (SONOBUSTER): A Randomized, Controlled trial. Eur Heart J 2015; doi: 10.1093/eurheartj/ehv492.[Ahead of Print].
    1. Školoudík D, Fadrná T, Bar M, et al. Changes in haemocoagulation in healthy volunteers after a 1-hour thrombotripsy using a diagnostic 2-4 MHz transcranial probe. J Thromb Thrombolysis 2008; 26:119–124.
    1. Ferguson GG, Eliasziw M, Barr HW, et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999; 30:1751–1758.
    1. Ringleb PA, Allenberg J, Bruckmann H, et al. The SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 368:1239–1247.
    1. Zhang YJ, Iqbal J, van Klaveren D, et al. Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: The SYNTAX Trial at 5-year follow-up. J Am Coll Cardiol 2015; 65:1107–1115.
    1. Masabni K, Raza S, Blackstone EH, et al. Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? J Thorac Cardiovasc Surg 2015; 149:1253–1260.
    1. Gerraty RP, Gates PC, Doyle JC. Carotid stenosis and perioperative stroke risk in symptomatic and asymptomatic patients undergoing vascular or coronary surgery. Stroke 1993; 24:1115–1118.
    1. Naylor AR, Mehta Z, Rothwell PM, et al. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg 2002; 23:283–294.
    1. Stamou SC, Hill PC, Dangas G, et al. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 2001; 32:1508–1513.
    1. Hogue CW, Jr, Murphy SF, Schechtman KB, et al. Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999; 100:642–647.
    1. D’Agostino RS, Svensson LG, Neumann DJ, et al. Screening carotid ultrasonography and risk factors for stroke in coronary artery surgery patients. Ann Thorac Surg 1996; 62:1714–1723.
    1. Schoof J, Lubahn W, Baeumer M, et al. Impaired cerebral autoregulation distal to carotid stenosis/occlusion is associated with increased risk of stroke at cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 2007; 134:690–696.
    1. Silvestrini M, Vernieri F, Pasqualetti P, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000; 283:2122–2127.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe